Virtual Reality Application During High Flow Nasal Oxygen Therapy in Children Effect on Anxiety Levels
Launched by USKUDAR UNIVERSITY · Mar 14, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Respiratory system diseases are frequently seen in childhood and hospitalised constitute a significant portion of the applications. Children continue their treatment in paediatric clinics or intensive care units according to their clinical conditions. In paediatric intensive care units, patients need respiratory support at various rates and respiratory support therapies are among the most commonly used treatment methods in paediatric intensive care clinics. Oxygen given to the appropriate patient under appropriate conditions treatment accelerates the healing process of the disease and preve...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The child is between 6-12 years old
- • The child is receiving high flow nasal cannula oxygen therapy in the paediatric intensive care unit
- • The child has no visual and hearing problems
- • No pain according to the Wong-Baker pain scale
- • No genetic, congenital, chronic or metabolic disease
- • Being conscious and able to communicate verbally
- • Written and verbal acceptance of the child and his/her parents to participate in the study after the information.
- Exclusion Criteria:
- • The child is in pain.
- • The child is taking a sedative medication
- • The child has a fever above 37°C
- • The child presented with a severe asthma attack
- • The child's saturation value was below 92% at the time of admission
Trial Officials
Tuğba KARAKUŞ TÜRKER
Study Director
Üsküdar University Faculty of Health Sciences
About Uskudar University
Uskudar University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing research and innovation in the fields of psychology, health sciences, and social sciences. As a clinical trial sponsor, Uskudar University leverages its extensive network of experts and cutting-edge facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the global body of scientific knowledge. The university emphasizes ethical research practices and collaboration with healthcare professionals, ensuring that its trials are designed to adhere to the highest standards of safety and efficacy. Through its clinical research initiatives, Uskudar University seeks to foster advancements in medical science and enhance the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, Sancaktepe, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported